Literature DB >> 7399322

Rectally administered prednisolone--evidence for a predominantly local action.

D A Lee, M Taylor, V H James, G Walker.   

Abstract

Plasma prednisolone levels have been compared in healthy volunteers and in patients suffering from idiopathic proctocolitis after the administration of standard retention enemata containing either prednisolone-21-phosphate or prednisolone metasulphobenzoate sodium. The levels were significantly lower after the latter, irrespective of the presence or degree of activity of the disease. Prednisolone metasulphobenzoate appeared to be as effective as the 21-phosphate ester for the treatment of proctocolitis in the few patients where the two drugs were compared. It seems possible that the beneficial effect of the form of therapy is exerted predominantly locally, rather than by systemic action.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399322      PMCID: PMC1420348          DOI: 10.1136/gut.21.3.215

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone-21-phosphate enemata.

Authors:  S G MATTS
Journal:  Br Med J       Date:  1961-01-21

2.  Studies on the absorption of hydrocortisone from the colon of patients with idiopathic ulcerative colitis.

Authors:  M PATTERSON
Journal:  Tex Rep Biol Med       Date:  1958

3.  Rectal hydrocortisone.

Authors:  J D NABARRO; A MOXHAM; G WALKER; J D SLATER
Journal:  Br Med J       Date:  1957-08-03

4.  Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.

Authors:  S S SANBAR; K M WEST
Journal:  J Med Liban       Date:  1961

5.  On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.

Authors:  S Halvorsen; J Myren; A Aakvaag
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

6.  Absorption of steroid hormones from the human small intestine.

Authors:  H P Schedl
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

7.  Prednisolone levels in the plasma and urine: a study of two preparations in man.

Authors:  J English; J Chakraborty; V Marks; D J Trigger; A G Thomson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

8.  Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.

Authors:  D A Lee; G M Taylor; V H James; G Walker
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

9.  Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.

Authors:  J Powell-Tuck; J E Lennard-Jones; C S May; C G Wilson; J W Paterson
Journal:  Br Med J       Date:  1976-01-24

10.  The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.

Authors:  D A Lee; G M Taylor; J G Walker; V H James
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

View more
  13 in total

Review 1.  Drug management of ulcerative colitis.

Authors:  M A Kamm; A Senapati
Journal:  BMJ       Date:  1992-07-04

Review 2.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

3.  Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis.

Authors:  R H Grace; A E Gent; M D Hellier
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

Review 4.  Medical treatment of ulcerative colitis.

Authors:  J E Lennard-Jones
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

Review 5.  Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

6.  Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.

Authors:  P B McIntyre; F A Macrae; L Berghouse; J English; J E Lennard-Jones
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 7.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

8.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

9.  Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.

Authors:  M Campieri; C Corbelli; P Gionchetti; C Brignola; A Belluzzi; G Di Febo; P Zagni; G Brunetti; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.

Authors:  T N Tozer; J Rigod; A D McLeod; R Gungon; M K Hoag; D R Friend
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.